MUC1 and breast carcinoma: conducted a study on breast cancer patients vaccinated with MUC1 peptide segments conjugated to KLH, revealing that while the immune response to KLH was enhanced, the MUC1-specific T-cell response showed limitations in consistency and intensity (177).